European Journal of Heart Failure

Advancing knowledge in the field of heart failure management

Showing 24 of 4833 results

What’s new in heart failure? September 2026
ESC Journals
What’s new in heart failure? September 2026
1 October 2026
Correction to: Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials
ESC Journals
Correction to: Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials
31 August 2026
Long-term effects of acoramidis on mortality in variant transthyretin amyloid cardiomyopathy, including p.Val142Ile: findings from the open-label extension of ATTRibute-CM
ESC Journals
Long-term effects of acoramidis on mortality in variant transthyretin amyloid cardiomyopathy, including p.Val142Ile: findings from the open-label extension of ATTRibute-CM
30 August 2026
Between hypotension and hypoperfusion: a hazardous pre-shock window after acute myocardial infarction
ESC Journals
Between hypotension and hypoperfusion: a hazardous pre-shock window after acute myocardial infarction
14 August 2026
Correction to: Catheter ablation in end-stage heart failure with atrial fibrillation: an hierarchical endpoint analysis of the CASTLE-HTx trial
ESC Journals
Correction to: Catheter ablation in end-stage heart failure with atrial fibrillation: an hierarchical endpoint analysis of the CASTLE-HTx trial
11 August 2026
Long-term impact of aficamten on patient-reported outcome measures in obstructive hypertrophic cardiomyopathy: results from FOREST-HCM
ESC Journals
Long-term impact of aficamten on patient-reported outcome measures in obstructive hypertrophic cardiomyopathy: results from FOREST-HCM
3 August 2026
Catheter ablation in end-stage heart failure with atrial fibrillation: an hierarchical endpoint analysis of the CASTLE-HTx trial
ESC Journals
Catheter ablation in end-stage heart failure with atrial fibrillation: an hierarchical endpoint analysis of the CASTLE-HTx trial
30 July 2026
MRA-induced eGFR decline—causes, consequences, and context
ESC Journals
MRA-induced eGFR decline—causes, consequences, and context
28 July 2026
Correction to: Prevalence, Characteristics and Cardiovascular and Non-Cardiovascular Outcomes in Patients with Heart Failure with Supra-Normal Ejection Fraction: Insight from the JROADHF Study
ESC Journals
Correction to: Prevalence, Characteristics and Cardiovascular and Non-Cardiovascular Outcomes in Patients with Heart Failure with Supra-Normal Ejection Fraction: Insight from the JROADHF Study
27 July 2026
Fast recovery in infarct-related cardiogenic shock: can we identify the patient who does not need mechanical support?
ESC Journals
Fast recovery in infarct-related cardiogenic shock: can we identify the patient who does not need mechanical support?
24 July 2026
Trends in mortality, heart transplantation, and left ventricular assist device use in advanced heart failure between 2003 and 2022: data from the Swedish Heart Failure Registry
ESC Journals
Trends in mortality, heart transplantation, and left ventricular assist device use in advanced heart failure between 2003 and 2022: data from the Swedish Heart Failure Registry
22 July 2026
Short-term survival of dual SGLT2i-MRA and four-class guideline-directed medical therapy in acute heart failure
ESC Journals
Short-term survival of dual SGLT2i-MRA and four-class guideline-directed medical therapy in acute heart failure
22 July 2026
From access to action in transthyretin amyloid cardiomyopathy: are we missing opportunities for therapy optimization?
ESC Journals
From access to action in transthyretin amyloid cardiomyopathy: are we missing opportunities for therapy optimization?
20 July 2026
Pre-shock in acute myocardial infarction: insights from the IABP-SHOCK II and CULPRIT-SHOCK trials
ESC Journals
Pre-shock in acute myocardial infarction: insights from the IABP-SHOCK II and CULPRIT-SHOCK trials
18 July 2026
A NETwork meta-analysis with COST-effectiveness evaluation of pharmacological treatments for heart failure with reduced ejection fraction: NET-COST-HFrEF
ESC Journals
A NETwork meta-analysis with COST-effectiveness evaluation of pharmacological treatments for heart failure with reduced ejection fraction: NET-COST-HFrEF
16 July 2026
Rethinking tricuspid regurgitation in heart failure—a pathophysiology-based holistic approach for individualized patient management
ESC Journals
Rethinking tricuspid regurgitation in heart failure—a pathophysiology-based holistic approach for individualized patient management
15 July 2026
Early SGLT2 inhibition in acute heart failure: when more urine does not necessarily mean better decongestion
ESC Journals
Early SGLT2 inhibition in acute heart failure: when more urine does not necessarily mean better decongestion
15 July 2026
First Italian multicentre registry for Mechanically Assisted Circulatory Support (ITAMACS) report: 12-year experience of over 1000 durable LVAD patients
ESC Journals
First Italian multicentre registry for Mechanically Assisted Circulatory Support (ITAMACS) report: 12-year experience of over 1000 durable LVAD patients
13 July 2026
European Society of Cardiology updated curriculum for heart failure nurses: developed by the Heart Failure Association, in collaboration with the Association of Cardiovascular Nurses and Allied Professions of the European Society of Cardiology
ESC Journals
European Society of Cardiology updated curriculum for heart failure nurses: developed by the Heart Failure Association, in collaboration with the Association of Cardiovascular Nurses and Allied Professions of the European Society of Cardiology
10 July 2026
Correction to: Association of patient-centred remote monitoring with clinical outcomes in patients with prior hospitalization: the TELESAT PRIOR-HF study
ESC Journals
Correction to: Association of patient-centred remote monitoring with clinical outcomes in patients with prior hospitalization: the TELESAT PRIOR-HF study
3 July 2026
sST2: a novel predictor of mortality risk in acute heart failure with reduced ejection fraction?
ESC Journals
sST2: a novel predictor of mortality risk in acute heart failure with reduced ejection fraction?
29 June 2026
sST2 and CA125 identify distinct biological phenotypes and predict mortality in very old patients hospitalised for acute HFpEF
ESC Journals
sST2 and CA125 identify distinct biological phenotypes and predict mortality in very old patients hospitalised for acute HFpEF
29 June 2026
efficacy and safety of mineralocorticoid receptor antagonists across geographical regions in heart failure: a patient-level pooled analysis
ESC Journals
efficacy and safety of mineralocorticoid receptor antagonists across geographical regions in heart failure: a patient-level pooled analysis
29 June 2026
Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials
ESC Journals
Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials
29 June 2026